Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$104.0 - $122.92 $2.51 Million - $2.96 Million
-24,101 Reduced 19.01%
102,690 $11.9 Million
Q4 2022

Feb 13, 2023

BUY
$84.98 - $122.67 $10.8 Million - $15.6 Million
126,791 New
126,791 $14.4 Million
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $3.49 Million - $6.83 Million
51,400 Added 162.15%
83,100 $6.19 Million
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $419,973 - $581,212
-4,464 Reduced 12.34%
31,700 $16.2 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $17,402 - $21,817
134 Added 0.37%
36,164 $19.4 Million
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $24,329 - $32,645
228 Added 0.64%
36,030 $19.7 Million
Q2 2021

Aug 16, 2021

BUY
$80.99 - $107.93 $291,725 - $388,763
3,602 Added 11.19%
35,802 $15.3 Million
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $2.73 Million - $3.37 Million
32,200 New
32,200 $11.6 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Engine No. 1 LLC Portfolio

Follow Engine No. 1 LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engine No. 1 LLC, based on Form 13F filings with the SEC.

News

Stay updated on Engine No. 1 LLC with notifications on news.